3.
不同预后因素对NSCLC患者生存期的影响（n=80）
Influence of different prognostic factors on survival time of NSCLC patients (n=80)
| Related factors | n | MST (month) | 95%CI | P |
| Age (year) | 0.4681 | |||
| ≤65 | 45 | 9.8 | 8.9-10.7 | |
| >65 | 35 | 11.2 | 9.6-12.8 | |
| Gender | 0.091 | |||
| Male | 55 | 10.8 | 9.5-12.1 | |
| Female | 25 | 9.7 | 9.2-10.2 | |
| Clinical stage | 0.572 | |||
| Ⅲ | 30 | 10.0 | 9.3-10.7 | |
| Ⅳ | 50 | 10.2 | 9.0-11.4 | |
| EOCG PS scores | 0.001 | |||
| 0 | 50 | 11.1 | 10.0-12.2 | |
| 1-2 | 30 | 9.4 | 6.9-11.9 | |
| Histology | 0.233 | |||
| Squamous cell carcinoma | 27 | 10.2 | 8.7-12.6 | |
| Adenocarcinoma | 42 | 9.4 | 8.5-10.3 | |
| WBC baseline level | 0.588 | |||
| ≤10 000/mm3 | 28 | 10.2 | 7.7-12.7 | |
| >10 000/mm3 | 52 | 10.0 | 9.1-10.9 | |
| OR | 0.012 | |||
| Yes | 21 | 12.2 | 11.5-12.9 | |
| No | 59 | 9.7 | 8.9-10.5 | |
| CYFRA21-1 response | < 0.001 | |||
| Yes | 34 | 12.3 | 11.6-13.0 | |
| No | 50 | 8.9 | 7.3-10.5 | |
| CYFRA21-1 baseline level | 0.001 | |||
| Normal | 8 | 9.0 | 6.2-11.8 | |
| >3.2 ng/mL | 72 | 10.7 | 9.8-11.6 |